Medical News Interviews
In the REVIVE trial the inotropic agent levosimendan has improved short-term outcome in acutely decompensated heart failure. Milton Packer from the University of Texas.
[audio:https://www.audiomedica.com/podcasting/aha2005/Milton_Packer.mp3]
Click here for all the interviews from AHA 2005
CABG better than pci in patients with diabetes and multi-vessel coronary disease 10 Nov, 2012 
Blood Pressure, Cholesterol, Smoking: Key Factors in New European Guidelines to Prevent Heart Disease 5 Sep, 2007 PREAMI: Perindopril Improves Remodelling in Older Patients with Acute Myocardial Infarction 12 Sep, 2005 Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006 16 Nov, 2006 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
